Loading clinical trials...
Loading clinical trials...
A Pivotal Randomized, Single-Blind, Dose-Finding Study to Evaluate Immunogenicity, Safety and Tolerability of Different Formulations of an Adjuvanted and Non-Adjuvanted Egg-Derived, Inactivated Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine in Healthy Pediatric Subjects 3 to < 9 Years of Age
Conditions
Interventions
MF59-eH1N1
Locations
35
United States
Premier Health Research Center, LLC
Downey, California, United States
Madera Family Medical Group
Madera, California, United States
Center for Clincal Trials, LLC
Paramount, California, United States
Center for Clinical Trials, LLC
Paramount, California, United States
Center for Clinical Trials of San Gabriel
West Covina, California, United States
1st International Research Centers
Thornton, Colorado, United States
Start Date
September 1, 2009
Primary Completion Date
November 1, 2009
Completion Date
October 1, 2010
Last Updated
April 14, 2016
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Novartis Vaccines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions